Huang Alan 4
4 · Tango Therapeutics, Inc. · Filed Aug 16, 2021
Insider Transaction Report
Form 4
Huang Alan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-12+169,859→ 169,859 totalExercise: $9.56Exp: 2031-08-12→ Common Stock (169,859 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.